United States of America National 5G Resolution


An Urgent Call for a Moratorium on 5th Generation Wireless  Technologies Pending Safety Testing

To:  Donald Trump, President of the United States of America 

December 11, 2019

We, the undersigned, are medical doctors, health professionals, scientists, engineers and public advocates who are deeply concerned about the potential health risks associated with 5G and the proliferation of electromagnetic radiation sources from wireless telecommunications technologies. 

The FCC has stated that 800,000 antenna sites will be required to fully deploy 5G in the United States. Global deployments are expected to reach almost 5 million by 2021. Industry projects 22 billion wirelessly connected devices worldwide as part of the Internet of Things. New wireless antennas are rapidly being attached to streetlights and utility poles directly in front of homes and schools. 5G will dramatically increase our daily exposure to radiofrequency electromagnetic fields (RF-EMF) in addition to the 2G, 3G, 4G, Wi-Fi, etc. RF-EMF from wireless infrastructure already in place that will continue to emit. The 5G antenna densification plan will lead to a significant increase of involuntary exposure to wireless radiation everywhere.

Cell phone and wireless were never premarket safety tested for long-term exposure to humans when they first came on the market decades ago. Now the harmful effects of non-ionizing electromagnetic exposure to humans and the environment are proven. In 2015, more than 250 scientists from more than 40 countries expressed their “serious concerns” in an EMF Appeal regarding the ubiquitous and increasing exposure to EMF generated by electric and wireless devices even before the additional 5G Internet of Things rollout. The scientists refer to the fact that “numerous recent scientific publications have shown that EMF affects living organisms at levels well below most international and national guidelines”. Since then, hundreds of doctors have signed onto new appeals specifically calling to halt 5G.

A large number of peer-reviewed scientific reports demonstrate harm to human health from EMFs. Effects include increased cancer risk, increased cellular stress, increased harmful free radicals, genetic damages, structural and functional changes of the reproductive system, learning and memory deficits, behavioral problems, neurological disorders, headaches, and negative impacts on general well-being in humans. Damage goes well beyond the human race, as there is growing evidence of harmful effects to trees, bees, plants, animals, and bacteria.

After the EMF scientists’ appeal was initiated in 2015, additional research has associated serious adverse biological effects of RF-EMF emissions from wireless technologies. The U.S. National Institutes of Health National Toxicology Program (NTP) published its large-scale, $30 million animal study showing DNA damage and statistically significant increases in the incidence of brain cancer and heart cancer in animals exposed daily to wireless radiation. These findings support the results from human epidemiological studies finding associations between wireless radiation and brain tumor risk.

The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization (WHO), in 2011 concluded that EMFs at frequencies 30 KHz to 300 GHz are possibly carcinogenic to humans (Group 2B). However, since that date, new studies, including the NTP study mentioned above and several epidemiological and experimental investigations, have increased the evidence indicating that wireless is carcinogenic. Now in 2019, the IARC announced plans to re-evaluate RF-EMF for carcinogenicity as soon as 2022. 

As the U.S. Department of the Interior stated, “the electromagnetic radiation standards used by the Federal Communications Commission (FCC) continue to be based on thermal heating, a criterion now nearly 30 years out of date and inapplicable today.” FCC guidelines only protect against heating effects (EPA 2002) and ignore the effects of pulse-modulated signals. Scientists have repeatedly found adverse biological effects that are caused without heating (”non-thermal effect”) at radiation levels far below the limits in FCC guidelines. Replicated research finds memory damage, behavioral problems and tumor promotion from “low” legally allowed levels of wireless.

As the EPA was defunded in the mid ‘90s, there are no federally developed safety limits and there is no health and safety agency in the United States with authority to review the research and ensure protections regarding the human health and environmental effects from wireless antennas. Internationally, the organizations that issue exposure standards have failed to develop sufficient guidelines. Published reviews and studies on the new higher frequencies to be used in 5G call for caution and warn of future impacts that will not only impact humans but also wildlife and especially bees.

We are concerned about the health and well-being of those who are most vulnerable: children, pregnant women, and persons sensitive to electromagnetic fields and who have chronic health problems.

We join with the thousands of doctors, scientists and health care providers worldwide who have recently issued appeals for urgent action on 5G to protect public health. The rapidly growing list includes the International EMF Scientist Appeal, Appeal to the European Union, Belgium Doctors Appeal, Canadian Doctors, Cyprus Medical Association, Physicians of Turin, Italy, the German Doctors Appeal, International Appeal to Stop 5G on Earth and Space and the International Society of Doctors for the Environment.

We call for a moratorium on 5G and any further wireless antenna densification until potential hazards for human health and the environment have been fully investigated by scientists independent from the wireless industry.  

Doctors or health practitioners who want to sign onto  this letter please email EHT at [email protected]

List of Signatories

Note: To sign please send your name, title and location to [email protected]

Signatories to the National 5G Resolution collected at the EMF Conference, September 2019

The resolution was attended the first U.S. medical conference fully dedicated to this topic, Electromagnetic Fields Conference on Diagnosis and Treatment”  convened in Scott’s Valley, California, from September 6-8, 2019.

As the conference was concluding, several participants agreed to initiate a National 5G Resolution, recommending a moratorium on the roll-out of fifth generation wireless, 5G, until potential hazards for human health and the environment have been fully investigated by scientists independent from the industry. 

Miguel Aguilera, MD, Milwaukee, Wisconsin 

Robin Anderson, PhD , Santa Rosa, California             

Wayne Anderson, ND,  Santa Rosa, California

Randy Baker, MD, Soquel, California

Stephanie Belseth, NP, Edina, Minnesota

Matthew Bernstein, MD, Chicago, Illinois

Andrea Berrin, MA, Aptos, California

Tara Boyd, ND, Seattle, Washington    

Robert Brown, MD Export, Pennsylvania

Sarah Carnes, ND Woodinville, Washington

Margaret Christensen, MD  Dallas, Texas

Rowena Chua, MD,  Glenview, Illinois

Tracey Cook, ND,  Orrville, Ohio                                                                                             

Deborah L. Dykema, DO,  Phoenix, Arizona

Eric Gordon, MD,   San Rafael, California                                                                                                                            

Cheryl Grey, MD, Boulder, Colorado

Devra Davis PhD, MPH, Jackson Hole Wyoming

Trudy Heil, NP, Portland, Oregon

Anne Hill, ND, Portland, Oregon

Lynn Hinkle, PA, ND,   Mill Valley, California

Tori Jelter, MD, Walnut Creek, California

Elizabeth Kelley, MA, Tucson, Arizona

Jennifer Kessman MD, IFMEP, ABFM,FAAFP, Dallas, Texas                                       

Kim Lear, MA,  Lyons, Colorado,

Kaiser Permanente, Northern California, 

Ronald Lynch, MD, Orlando, Florida                    

Karl Maret, MD, MA, Corralitos, California

Dorota Matusewicz, MD,  Clearwater, Florida

Kelly McCann, MD, Costa Mesa, California                                                                                                                            

Lisa Nagy, MD, Martha’s Vineyard, MA

Bonnie Nedrow, ND,  President, National Association of Environmental Medicine

Kalpana D. Patel, MD, Buffalo, New York

  Victoria Nee, MD, Chicago, Illinois                     

Daniel Rieders, MD, Palo Alto, California 

Stephanie Riley, ND, Truckee, California  

Sandra Ross, PhD., Mill Valley, California

Marly Sachsman, ND, Ellsworth, Maine      

Natalie Sadler, MD, Black Mountain, North Carolina                                                   

Glayol Sahba, MD,  Sacrament, California                                                                                                                            

Christine Salter, MD, St. Louis, Missouri

Lindsay Samuelson, ND, Toledo, Ohio                     

Lisa Saslove, MS, RD, Sebastopol, California 

Elizabeth H. Sims-Day, ND, Lake Forest Park, Washington 

Therese Stokan, DO, Port Angeles, Washington                                                                                                                

Irina Strelyuk, ND, San Rafael, California                       

Wallace Taylor, MD, Austin, Texas                                                                                                                                 

Veronica Tilden, DO, Nevada City, California   

Diana Vandegriff, NMD, Tempe, Arizona                                                                                                                                                    

Elizabeth Vaughn, MD, High Point, North

Carolina Kathy Veon, DOM, AP, CCN, Orlando, Florida                    

Kevin Wand, DO,  Bloomington,Minnesota                                                                                                                          

Melody Wong, ND, Burlingame, California

Mina Yoon, ND, LAC, San Francisco, California

Sarah Aminoff, Union City, California         

Laura Bobzien, Dallas, Texas           

August Brice, Founder, Tech Wellness California

Susan Busen, Palos Heights, Illinois

Nancy Costa, Heartfelt Spaces, San Rafael, California    

Teresa Demarie, MBA, Long Beach, California      

Jennifer Crumpton,  Austin, Texas         

Shilpa Dashpute, MA,  Glendora, California  

Cecelia Doucette, MTPW, Ashland, Massachusetts      

Michael Garabedian, Attorney, Lincoln, California             

David Getoff, CNN, CTN, FAAIM   Vice President, Price Pottenger Nutrition Foundation                

William Holland,  Topanga, California                

Mieke Jacobs,  Lake Zurich, Illinois       

Monika Karajewski, Santa Barbara, California

Miriam Lindbeck,    Santa Barbara, California 

Rola Masri,  Los Angeles, California

Cheryl Matthews, Los Altos Hills, California      

Lloyd Morgan, EE,  Berkeley, California       

Kevin Mottus. LCSW,  Los Angeles, California   

Reilley Mullin, FNP, Trinidad, California                

Ajna Orion,  Felton, California                                                                                                                             

Cynthia Quattro, PA, LAc, Soquel, California      

Theresa Ricker,  San Antonio, Texas     

Theodora Scarato MSW, Environmental Health Trust

Stephen Scott,  Novato, California    

Taryn Slauson,   Santa Fe, New Mexico                                          

Leslie Stalder, LC,  Arcata, California               

Amber Stokes, Med,  Santa Monica, California  

Sam Wieder, MBA,  Greenville, Pennsylvania

Eric Windheim, BBEC, EMRS, Sacramento, California

Nasha Winters, ND, LAc, FABND,  Durango, Colorado                 

Glenn Kikel, ACN, Lyons, Colorado        

Mary Anne Tierney, RN, MPH,   Ashville, North Carolina

SOURCE L INK….

How prohibition limits cannabis & technology

Published on February 7, 2017

Travis Lachner

Travis Lachner
CEO & Creative Director at Cannvas

 

Federal prohibition segregates cannabis and technology.

Complex banking regulation suffocates cash flow.

Research discoveries are suppressed and hidden.

Social media shutdowns are routine procedure.

Simply stated; making progress in the cannabis industry is really difficult right now.

This professional canna-bigotry is due to marijuana’s (mis)classification as a Schedule I substance. Domestic and international companies

Most of the country supports cannabis legalization. Yet, it still remains illegal.

Prohibition causes unnecessary and inefficient problems for the industry – and the nation.

We need to end prohibition and build the industry right to realize the potential of cannabis.

Companies, consumers, patients, and citizens will all benefit from proper legalization.

1) Banking and FinTech access sucks. Cash-only operations are unsafe.

Cannabis companies cannot access basic banking and financial technologies normally.

Federal prohibition restricts most banks from serving companies related to cannabis in any way. Even ancillary companies (that don’t touch the plant) are still neglected.

And legislative progress for cannabis banking created at the state level is stomped out by federal government.

In Colorado, state banking officials approved a charter for the first “Cannabis Bank” ever – A credit union named The Fourth Corner (TFCCU).

However, final admin approval at the federal level is continuously denied… The cannabis bank cannot operate without it.

Financial restrictions force cannabis companies two directions:

  • Option A – Companies operate cash only. Sometimes moving hundreds of thousands of dollars at a time.
  • Option B – Companies pursue private banking opportunities at the state level and operate within financial loopholes.

Neither of these options are ideal.

According to Bloomberg Business, less than 3% of banks in America accept cannabis cash. Which means employees and individuals must move billions of dollars in cash regularly. These are extremely unsafe conditions and procedures.

A new “cannabis security” industry is emerging because of this problem. Ventures like Canna Security America provide comprehensive security services to keep staff, customers, and citizens safe.

But cannabis companies shouldn’t have to hire armed security services for safety… If customers were allowed to just swipe a damn debit card at any dispensary, the context of cannabis will be safer.

Modern banking technology is essential to all modern companies. Why are cannabis companies forced into awkward and unsafe restrictions?

It is unrealistic to make companies to operate under such irrational conditions. Especially while being taxed so heavily.

2) Awkward and vague regulations change often.

Cannabis companies pour capital into compliance. The “cover your ass” attitude is necessary in the ever-shifting regulations and requirements.

Brands balance between state legality and federal prohibition. New laws can make, break, or change business models overnight.

In addition to operational regulation, cannabis companies must abide to marketing and advertising restrictions. They cannot reach audiences like most other businesses.

Traditional companies in America spend millions on marketing and advertising – with minimal restrictions. TV, Facebook, Google, Instagram – pretty much whatever they want. But cannabis related companies can’t participate. (Yet.)

Instead, cannabis companies navigate complex layers of ambiguous regulation. Many areas of requirements are unclear, unrealistic, or nonexistent.

Large companies like Google and Facebook restrict ads for anything and everything cannabis-related.

And to be fair, they are just protecting their companies. Most of these policies are indirectly due to federal prohibition.

National brands fear the possible repercussions of the federal government. So they cover their ass by following suit with whatever the government says at the time.

This creates a contradicting scenario for companies and states… Selling cannabis is legal – but advertising cannabis is tricky.

Beyond regulation, cannabis companies are often pushed around by the “big boys” of media and technology.

I see new stories like those every week. It’s seriously like industrial level bigotry or bullying.

3) Research and development efforts are limited and discouraged.

Cannabis companies cannot complete high-level research and development.

Innovation research and medical studies require strict government approval or federal funding – which is often denied.

But here’s the weird part. The federal government already knows cannabis research will benefit society… The federal government owns the patent to use cannabinoids as antioxidants and neuroprotectants. Yet, they still suppress innovative discoveries.

Back in the 70’s, the US government discovered THC can shrink cancerous tumors. But political forces swept this research under the rug.

Why? Because it did not support the agenda for “The War on Drugs.”

Modern research reinforced the discovery again in 2000.

Spanish scientists successfully destroyed “uncurable” brain tumors with THC (an active component of cannabis).

But you probably didn’t see this story in America. That’s because the revolutionary research was censored and ignored by major media outlets.

The neglected study from Madrid was named the “Top Censored Story” of 2000 by Project Censored

Today, American government is still putting up roadblocks for research.

In 2015, Congress shut down federal research on medical marijuana yet again.

This is an absurd problem. Is our own government suppressing the potential power of cannabis intentionally?

The medical benefits of cannabis and technology deserve to be discovered and delivered to the people.

Let’s take a closer look at the potential of marrying cannabis and technology.

Throughout history, technology innovations pave the path for industries to leverage and build upon.

But unfortunately, cannabis companies are restricted from leveraging existing technologies.

While most American companies sit on the shoulders of giants, cannabis companies barely get to stand on on the big toe of that giant.

Even worse – companies that “touch the plant” are restricted by regulations and fear of prosecution. Which means new innovations in the industry are often discouraged or dismissed.

This type of environment creates irrational risk for entrepreneurs, researchers, and innovators. It discourages progress and big ideas..

Instead, we must cultivate an environment for encouraging positive growth and development.

Imagine what we will gain when the cannabis industry can leverage the entire spectrum of modern technologies with less restriction.

1) Companies will focus on improving products and services.

Cannabis companies will devote more time and energy to optimize the customer experience. Products and services will be fixed, upgraded, and optimized over time.

Currently, cannabis companies spend TONS of time, money, and energy navigating a shit-show of regulations and compliance.

Intense, time-consuming administrative projects ensure the entire business isn’t stripped away.

This energy could be (and should be) spent better.

Internal resources should be used to enhance product development, improve services, and innovate the customer experience.

Cannabis companies deserve the right to allocate their bandwidth more efficiently.

2) Companies will mature their marketing (and targeting).

Marketing and advertising will experience noticeable maturity. Companies will focus on more specific target audiences with hyper-detailed precision.

Cannabis companies will target consumers and patients better.

From stereotypical “stoners” to critically concerned medical patients… Proper access to modern marketing and targeting technology will enhance the customer experience.

Customer archetypes, strain-matching, and advanced targeting tools will be standard in the industry. Apps like PotBot will offer custom product recommendations based on user preferences.

Technology allows brands to target the exact type of users best-fit for their product. In the end, that is better for both the consumers and the companies.

But most technologies will be inaccessible or restricted until prohibition is lifted.

Federal prohibition sets the tone for large companies and advertising platforms to follow suit regarding cannabis. And the current advertising restrictions make it extremely difficult for companies to capture targeted audiences.

Cannabis pioneers experience difficulty building and marketing effective, creative and compliant campaigns.

If this problem sounds familiar… Cannvas provides custom cannabis brand-building solutions for 100% compliant marketing, advertising, and PR.

3) Research will unlock the power of the endocannabinoid system.

This is the big kahuna.

The endocannabinoid system is the untapped holy grail of cannabis and medicine.

It could be one the missing key needed to treat, manage, or cure many conditions in the medical community.

The endocannabinoid system is revolutionary. But we are only in the early stages of discovery. Many experts predict mastering the ECS will mark a new era of healthcare.

From cancer, to epilepsy, to simple chronic pain or nausea… The endocannabinoid system is directly related to the biological balance of humans.

Currently, we are just scratching the surface of possibilities. But the convergence of cannabis and medical technology is well under way.

With proper funding, and federal approval, hundreds of medical benefits will be discovered. The full potential of can be literally life-saving.

Cannabis will soon develop its identity as a wellness product.

And canna-pharmaceuticals may be the future of healthcare.

The solution is simple.

Federal prohibition is ineffective. We need to marry cannabis and modern technologies.

Nationwide legalization will enable better access to existing technologies – while encouraging innovation and safety.

Companies, consumers, and citizens will all benefit from legalizing cannabis.

And we can build the industry right.

Let’s do this.